MedPath

Efficacy of Ezetimibe vs Rosuvastatin In Impaired Glucose Tolerance Hypercholesterolemia to Treat

Phase 4
Conditions
Hypercholesterolemia
Registration Number
JPRN-UMIN000008049
Lead Sponsor
Jikei University School of Medicine,Kashiwa Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

1) HbA1c>=6.5%(NGSP) 2) Hypersensitivity to test agents 3) Treating with antihyperlipidemic agents other than rosuvastatin 4) Severe hepatic dysfunction: any one of following (i)AST>=100IU/L (ii)ALT>=100IU/L (iii)Cirrhosis 5) Severe renal dysfunction: serum creatinine>=2.0mg/dL 6) History of acute coronary syndrome(myocardial infarction, angina) and stroke within 3 months 7) Secondary hyperlipidemia, drug induced hyperlipidemia 8) Pregnant, breast-feeding, becoming pregnant 9) Familial hypercholesterolemia 10) Inadequate to this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath